US FDA approves Lilly's Alzheimer's drug
The U.S. Food and Drug Administration on Tuesday gave a green light to Eli Lilly's donanemab for patients with early Alzheimer's, making it the second approved drug for slowing the progress ...
Reuters via Yahoo
13 minutes ago